今日盘中，港股上市公司微创医疗（00853）股价大涨6.15%，引发市场关注。此轮上涨或与近期公司引入战略投资者有关。
据悉，上海生物医药并购基金近期宣布拟通过协议转让方式收购Otsuka Medical Devices Co., Ltd.持有的微创医疗1.35亿股份，成为微创医疗的战略股东。这笔交易的市场价值约在14亿至15亿港元。上海生物医药并购基金表示，将依托国资背景和产业资源，持续关注微创医疗的发展需求，在符合市场规则和战略协同的前提下，助力其核心业务拓展及潜在战略并购。
此外，南向资金也显示出对微创医疗的青睐。数据显示，7月30日南向资金增持微创医疗2577.44万股。近20个交易日，微创医疗股价上涨52.78%，港股通累计增持7757.32万股。这种持续的资金流入可能进一步推动了股价的上涨。微创医疗作为国产创新医疗器械龙头公司，其业务已拓展至多个领域，包括心律管理、骨科、心血管介入等，拥有多家上市公司和高新技术企业，显示出强劲的发展潜力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.